Title |
Association of Developmental Venous Anomalies with Demyelinating Lesions in Patients with Multiple Sclerosis
|
---|---|
Published in |
American Journal of Neuroradiology, September 2017
|
DOI | 10.3174/ajnr.a5374 |
Pubmed ID | |
Authors |
D.M. Rogers, M.E. Peckham, L.M. Shah, R.H. Wiggins |
Abstract |
We present 5 cases of demyelination in patients diagnosed with multiple sclerosis that are closely associated with a developmental venous anomaly. Although the presence of a central vein is a known phenomenon with multiple sclerosis plaques, demyelination occurring around developmental venous anomalies is an underreported phenomenon. Tumefactive demyelination can cause a diagnostic dilemma because of its overlapping imaging findings with central nervous system neoplasm. The relationship of a tumefactive plaque with a central vein can be diagnostically useful, and we suggest that if such a lesion is closely associated with a developmental venous anomaly, an inflammatory or demyelinating etiology should be a leading consideration. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 7 | 22% |
Italy | 5 | 16% |
Canada | 4 | 13% |
Spain | 2 | 6% |
Netherlands | 1 | 3% |
Switzerland | 1 | 3% |
United Kingdom | 1 | 3% |
Unknown | 11 | 34% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 26 | 81% |
Practitioners (doctors, other healthcare professionals) | 3 | 9% |
Science communicators (journalists, bloggers, editors) | 2 | 6% |
Scientists | 1 | 3% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 21 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Other | 4 | 19% |
Researcher | 3 | 14% |
Student > Postgraduate | 3 | 14% |
Student > Ph. D. Student | 2 | 10% |
Student > Doctoral Student | 1 | 5% |
Other | 2 | 10% |
Unknown | 6 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 9 | 43% |
Neuroscience | 5 | 24% |
Psychology | 1 | 5% |
Unknown | 6 | 29% |